Top of page
Main Content

Vibration therapy to help prostate cancer patients

Thursday, 17 November 2011


Researchers have been awarded $55,000 to investigate how vibration therapy could help in the fight against prostate cancer.

The Australian Unity Heritage Foundation awarded the fellowship grant to ECU’s Health and Wellness Institute, located on the Joondalup Campus.

More than 2,000 men undergo androgen suppression therapy (AST) for prostate cancer each year in Australia. The therapy is used to suppress the production of testosterone, and its effects on cancerous cells.

The bone density of patients with prostate cancer can be compromised if they undergo AST as part of their treatment.

Vibration stimulus therapy has been identified as a treatment which can improve or maintain bone density.

Health and Wellness Institute Post Doctoral Research Fellow Dr Carolyn McIntyre predicts that vibration stimulus therapy will be very beneficial to patients undergoing AST.

“Our study will investigate a new approach to long-term chronic disease management,” Dr McIntyre said.

“We believe that the final outcome will show that vibration therapy can prevent bone density deterioration in men with prostate cancer on AST. This may ultimately result in reduced morbidity and mortality for men with prostate cancer.”

Health and Wellness Institute Postdoctoral research fellows Dr Michael Baker and Prue Cormie, Professor Rob Newton, and Associate Professor Daniel Galvão are co-investigators on the project.

Share

Skip to top of page